Phase 3 β Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(31 sites)
United States
Academic Medical Research Institute, Los Angeles, California North America Research Institute, San Dimas, California Valiance Clinical Research, Tarzana, California RecioMed Clinical Research Network, Inc., Boynton Beach, Florida South Florida Nephrology Research, Coral Springs, Florida Therafirst Medical Center, Fort Lauderdale, Florida Reliant Medical Research, LLC, Miami, Florida Vista Health Research, LLC, Miami, Florida Genesis Clinical Research, Tampa, Florida Fides Clinical Research, Atlanta, Georgia Costal Medical Research, Brunswick, Georgia Insight Hospital and Medical Center Chicago, Chicago, Illinois University of Iowa, Iowa City, Iowa Center for Advanced Kidney Research, PLC, Saint Clair Shores, Michigan NYU Langone Health, New York, New York Prolato Clinical Research Center, Houston, Texas P&I Clinical Research LLC, Lufkin, Texas University of Virginia, Charlottesville, Virginia Nephrology Associates of Northern Virginia, Fairfax, Virginia Canada
Regional Kidney Wellness Centre, Brampton, Ontario India
Vedanta Hospitals, Guntur, Andhra Pradesh Vijaya Super Speciality Hospital, Nellore, Andhra Pradesh AIIMS, Raipur, Chhattisgarh Muljibhai Patel Urological Hospital, NadiΔd, Gujarat KLE Hospital, Belagavi, Karnataka Saraswati Kidney Care Center, Nagpur, Maharashtra Sir Ganga Ram Hospital, New Delhi, National Capital Territory of Delhi PGIMER, Chandigarh, Punjab SMS Medical College and Hospital, Jaipur, Rajasthan Apex Hospitals, Jaipur, Rajasthan Galaxy Hospital, Varanasi, Uttar Pradesh